The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the ...
Hosted on MSN11d
Qiagen scoops FDA clearance for gastrointestinal panelQIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in ...
Throughout last year, Qiagen was granted FDA clearance for four QIAstat-Dx ... QIAstat-Dx system operations in Esplugues de Llobregat, Barcelona, Spain. Due to open early next year, the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback